Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment

References

• Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89:3354 - 60; PMID: 9129042
   PubMed Web of Science ®Google Scholar
• Rojewski MT, Baldus C, Knauf W, Thiel E, Schrezenmeier H. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation. Br J Haematol 2002; 116:555 - 63; http://dx.doi.org/10.1046/j.0007-1048.2001.03298.x; PMID: 11849211
   PubMed Web of Science ®Google Scholar
• Liu Q, Hilsenbeck S, Gazitt Y. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. Blood 2003; 101:4078 - 87; http://dx.doi.org/10.1182/blood-2002-10-3231; PMID: 12531793
   PubMed Web of Science ®Google Scholar
• Nimmanapalli R, Bali P, O’Bryan E, Fuino L, Guo F, Wu J, Houghton P, Bhalla K. Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells. Cancer Res 2003; 63:7950 - 8; PMID: 14633726
   PubMed Web of Science ®Google Scholar
• Seol JG, Park WH, Kim ES, Jung CW, Hyun JM, Kim BK, Lee YY. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem Biophys Res Commun 1999; 265:400 - 4; http://dx.doi.org/10.1006/bbrc.1999.1697; PMID: 10558879
   PubMed Web of Science ®Google Scholar
• Ai Z, Lu W, Qin X. Arsenic trioxide induces gallbladder carcinoma cell apoptosis via downregulation of Bcl-2. Biochem Biophys Res Commun 2006; 348:1075 - 81; http://dx.doi.org/10.1016/j.bbrc.2006.07.181; PMID: 16904648
   PubMed Web of Science ®Google Scholar
• Uslu R, Sanli UA, Sezgin C, Karabulut B, Terzioglu E, Omay SB, Goker E. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin Cancer Res 2000; 6:4957 - 64; PMID: 11156257
   PubMed Web of Science ®Google Scholar
• Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 2001; 61:5432 - 40; PMID: 11454688
   PubMed Web of Science ®Google Scholar
• Chiu HW, Ho YS, Wang YJ. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin. J Mol Med (Berl) 2011; 89:927 - 41; http://dx.doi.org/10.1007/s00109-011-0763-1; PMID: 21594580
   PubMed Web of Science ®Google Scholar
• Hyun Park W, Hee Cho Y, Won Jung C, Oh Park J, Kim K, Hyuck Im Y, Lee MH, Ki Kang W, Park K. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem Biophys Res Commun 2003; 300:230 - 5; http://dx.doi.org/10.1016/S0006-291X(02)02831-0; PMID: 12480548
   PubMed Web of Science ®Google Scholar
• Grad JM, Bahlis NJ, Reis I, Oshiro MM, Dalton WS, Boise LH. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 2001; 98:805 - 13; http://dx.doi.org/10.1182/blood.V98.3.805; PMID: 11468182
   PubMed Web of Science ®Google Scholar
• Vuky J, Yu R, Schwartz L, Motzer RJ. Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma. Invest New Drugs 2002; 20:327 - 30; http://dx.doi.org/10.1023/A:1016270206374; PMID: 12201495
   PubMed Web of Science ®Google Scholar
• Kuwabara I, Liu FT. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 1996; 156:3939 - 44; PMID: 8621934
   PubMed Web of Science ®Google Scholar
• Inohara H, Akahani S, Raz A. Galectin-3 stimulates cell proliferation. Exp Cell Res 1998; 245:294 - 302; http://dx.doi.org/10.1006/excr.1998.4253; PMID: 9851870
   PubMed Web of Science ®Google Scholar
• Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002; 277:6852 - 7; http://dx.doi.org/10.1074/jbc.M107668200; PMID: 11724777
   PubMed Web of Science ®Google Scholar
• Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000; 156:899 - 909; http://dx.doi.org/10.1016/S0002-9440(10)64959-0; PMID: 10702407
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Fukumori T, Raz A. Galectin-3 and metastasis. Glycoconj J 2004; 19:543 - 9; http://dx.doi.org/10.1023/B:GLYC.0000014084.01324.15; PMID: 14758078
   PubMed Web of Science ®Google Scholar
• Fukumori T, Kanayama HO, Raz A. The role of galectin-3 in cancer drug resistance. Drug Resist Updat 2007; 10:101 - 8; http://dx.doi.org/10.1016/j.drup.2007.04.001; PMID: 17544840
   PubMed Web of Science ®Google Scholar
• Fukumori T, Oka N, Takenaka Y, Nangia-Makker P, Elsamman E, Kasai T, Shono M, Kanayama HO, Ellerhorst J, Lotan R, et al. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res 2006; 66:3114 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-05-3750; PMID: 16540661
   PubMed Web of Science ®Google Scholar
• Cheng YL, Huang WC, Chen CL, Tsai CC, Wang CY, Chiu WH, Chen YL, Lin YS, Chang CF, Lin CF. Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli. Biochem Biophys Res Commun 2011; 412:334 - 40; http://dx.doi.org/10.1016/j.bbrc.2011.07.099; PMID: 21821001
   PubMed Web of Science ®Google Scholar
• Yu F, Finley RL Jr., Raz A, Kim HR. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 2002; 277:15819 - 27; http://dx.doi.org/10.1074/jbc.M200154200; PMID: 11839755
   PubMed Web of Science ®Google Scholar
• Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 2000; 14:262 - 70; http://dx.doi.org/10.1038/sj.leu.2401650; PMID: 10673743
   PubMed Web of Science ®Google Scholar
• Han B, Zhou G, Zhang Q, Zhang J, Wang X, Tang W, Kakudo K. Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp. J Exp Ther Oncol 2004; 4:335 - 42; PMID: 15844663
   PubMedGoogle Scholar
• Akay C, Thomas C 3rd, Gazitt Y. Arsenic trioxide and paclitaxel induce apoptosis by different mechanisms. Cell Cycle 2004; 3:324 - 34; http://dx.doi.org/10.4161/cc.3.3.657; PMID: 14726646
   PubMed Web of Science ®Google Scholar
• Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, Pienta KJ, Raz A. Regulation of prostate cancer progression by galectin-3. Am J Pathol 2009; 174:1515 - 23; http://dx.doi.org/10.2353/ajpath.2009.080816; PMID: 19286570
   PubMed Web of Science ®Google Scholar
• Aravena C, Beltrán AR, Cornejo M, Torres V, Díaz ES, Guzmán-Gutiérrez E, Pardo F, Leiva A, Sobrevia L, Ramírez MA. Potential role of sodium-proton exchangers in the low concentration arsenic trioxide-increased intracellular pH and cell proliferation. PLoS One 2012; 7:e51451; http://dx.doi.org/10.1371/journal.pone.0051451; PMID: 23236503
   PubMedGoogle Scholar
• Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 1996; 93:6737 - 42; http://dx.doi.org/10.1073/pnas.93.13.6737; PMID: 8692888
   PubMed Web of Science ®Google Scholar
• Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 1997; 57:5272 - 6; PMID: 9393748
   PubMed Web of Science ®Google Scholar
• Hanada M, Aimé-Sempé C, Sato T, Reed JC. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem 1995; 270:11962 - 9; PMID: 7744846
   PubMed Web of Science ®Google Scholar
• Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim HR, Bresalier RS, Raz A. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 2004; 24:4395 - 406; http://dx.doi.org/10.1128/MCB.24.10.4395-4406.2004; PMID: 15121858
   PubMed Web of Science ®Google Scholar
• Wang Y, Nangia-Makker P, Balan V, Hogan V, Raz A. Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment. Cell Death Dis 2010; 1:e101; http://dx.doi.org/10.1038/cddis.2010.79; PMID: 21368866
   PubMedGoogle Scholar